The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care 2007;30:1581–1583
In the appendix section of the article listed above, the affiliations for Makoto Sawaguchi and Nobuo Shirahashi are incorrectly listed as Shiga University of Medical Science and Osaka City University, respectively. The correct affiliation for both investigators is Novartis Pharma K.K.